TNXP

Tonix Pharmaceuticals Holding Corp.

SEC CIK 1430306
$11.52 −22.9% · 90 days
90-day buys
$180.3K
3 open-market
90-day sells
$0
0 open-market
Net insider flow
+$180.3K
Net buying
Filings shown
7
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at TNXP have bought a net $180.3K of stock (3 open-market buys vs 0 sells).

Largest recent trade: Lederman Seth, TNXP's CEO, spent $223.4K of their own money on 15,000 shares at $15, growing their stake 1500000%.

Most active filer: Lederman Seth, with 4 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for TNXP, newest first
View on SEC EDGAR ↗
TNXP
Buy LEDERMAN SETH · Director, Chief Executive Officer · Open-market purchase · filed 1w ago ΔOwn +125%

Lederman Seth, TNXP's CEO, spent $59K of their own money on 5,000 shares at $12, growing their stake 125%.

+$59K
5,000 sh @ $12
TNXP
Buy LEDERMAN SETH · Director, Chief Executive Officer · Open-market purchase · filed Apr 1, 2026 ΔOwn +33%

Lederman Seth, TNXP's CEO, spent $63.1K of their own money on 5,000 shares at $13, growing their stake 33%.

+$63.1K
5,000 sh @ $13
TNXP
Buy LEDERMAN SETH · Director, Chief Executive Officer · Open-market purchase · filed Mar 18, 2026 ΔOwn +999%

Lederman Seth, TNXP's CEO, spent $223.4K of their own money on 15,000 shares at $15, growing their stake 1500000%.

+$223.4K
15,000 sh @ $15
TNXP
Buy Taylor Carolyn E. · Director · Open-market purchase · filed Aug 21, 2025 ΔOwn NEW

Taylor Carolyn E., TNXP's Director, spent $15.1K of their own money on 418 shares at $36, opening a brand-new position.

+$15.1K
418 sh @ $36
Advertisement
TNXP
Buy Treco James · Director · Open-market purchase · filed Aug 20, 2025 ΔOwn NEW

Treco James, TNXP's Director, spent $9K of their own money on 250 shares at $36, opening a brand-new position.

+$9K
250 sh @ $36
TNXP
Buy LEDERMAN SETH · Director, Chief Executive Officer · Open-market purchase · filed May 15, 2025 ΔOwn +999%

Lederman Seth, TNXP's CEO, spent $86.2K of their own money on 4,000 shares at $22, growing their stake 80000%.

+$86.2K
4,000 sh @ $22
Advertisement

About TNXP insider activity

This page tracks every recent Form 4 filed for Tonix Pharmaceuticals Holding Corp. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is TNXP insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Tonix Pharmaceuticals Holding Corp. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.